Mid-treatment imaging can be used to de-escalate therapy for oropharynx cancer, leading to fewer side effects
A new phase II trial finds that PET scans obtained before and midway through treatment for p16-positive oropharynx cancer (OPC) can help determine whether a patient can receive a lower dose of radiation therapy in the second ...
Feb 24, 2022
0
3